Adverse Events Following COVID-19 Vaccination among the Beneficiaries of Sikkim Manipal University: A Cross Sectional Study

Authors

  • Jayden Lhamu Bhutia Sikkim Manipal Institute of Medical Sciences, Gangtok https://orcid.org/0000-0002-2439-9779
  • Binu Upreti Sikkim Manipal Institute of Medical Sciences, Gangtok
  • Eden Jamyang Bhutia Sikkim Manipal Institute of Medical Sciences, Gangtok
  • Sumit Kar Sikkim Manipal Institute of Medical Sciences, Gangtok
  • Forhad Akhtar Zaman All India Institute of Medical Sciences, Guwahati https://orcid.org/0000-0001-6234-3875

DOI:

https://doi.org/10.47203/IJCH.2021.v33i04.011

Keywords:

Covid-19 Vaccine, Covishield, Adverse Events, AEFI, Side Effects

Abstract

Background: Covid-19, an infection caused by SARS- CoV2 has claimed millions of lives since late 2019 with no curative measures. In India, 4 vaccines have been approved for use i.e. Serum Institute’s Covishield, Bharat Biotech’s Covaxin, GRIEM’s Sputnik V and Moderna’s Covid-19 vaccine. Aims: This study aims to find the adverse events following Covishield vaccination among the beneficiaries of Sikkim Manipal University, Sikkim. Material &Methods: A cross sectional study was conducted among the beneficiaries of Sikkim Manipal University to find out the adverse events following the first dose of vaccination. The data was collected using a self-administered questionnaire when the beneficiaries came for their second dose of vaccination. Microsoft Excel and SPSS version 27 was used for statistical analysis. Results: Out of 716 study participants majority i.e. 79.5% of the study participants developed adverse events following their first dose with maximum (73.8%) complaining of pain at the site of infection followed by fever (65.2%). Conclusions: Vaccines may prevent diseases, but it also brings about adverse effects, be it minor or major. Hence, many studies are required to study their full-fledged side effects and the means to overcome them.

Downloads

Download data is not yet available.

References

World Health Organization. 2019-nCoV outbreak is an emergency of international concern[Internet]. 2020 (Accessed on 28/12/2021). Available from: https://www.euro.who.int/en/health-topics/health-emergencies/international-health-regulations/news/news/2020/2/2019-ncov-outbreak-is-an-emergency-of-international-concern

Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet infectious diseases.2020;20(5):533-4. https://doi.org/10.1016/S1473-3099(20)30120-1

Jones L,PalumboD,BrownD.Coronavirus: How the pandemic has changed the world economy[Internet].2021.BBC(Accessed on 28/12/2021).Available from : https://www.bbc.com/news/business-51706225

Vuj?i? I, Safiye T, Miliki? B, Popovi? E, Dubljanin D, Dubljanin E, Dubljanin J, ?abarkapa M. Coronavirus Disease 2019 (COVID-19) Epidemic and Mental Health Status in the General Adult Population of Serbia: A Cross-Sectional Study. International Journal of Environmental Research and Public Health. 2021;18(4):1957. https://doi.org/10.3390/ijerph18041957

Batra K, Sharma M, Batra R, Singh TP, Schvaneveldt N. Assessing the psychological impact of COVID-19 among college students: an evidence of 15 countries. InHealthcare 2021;9(2):222). Multidisciplinary Digital Publishing Institute.https://doi.org/10.3390/healthcare9020222

Pinghui Z. Coronavirus: WHO backed China’s emergency use of experimental vaccines, health official says [Internet].South China Morning Post. Accessed on 28/12/2021. Available from :https://www.scmp.com/news/china/society/article/3103121/coronavirus-who-backed-chinas-emergency-use-experimental

Kramer A E. Russia Is Slow to Administer Virus Vaccine Despite Kremlin’s Approval[Internet].The New York Times.Published Sept. 19, 2020.Updated Nov. 24, 2020. Accessed on 28/12/2021. Available from :https://www.nytimes.com/2020/09/19/world/europe/russia-coronavirus-vaccine.html

MHRA. Information for healthcare professionals on Pfizer-BioNTech Covid-19 vaccine [Internet].Updated 2021 Jan 28.Accessed on 28/12/2021. Available from : https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine

Bahrain News Agency. Bahrain second in the world to approve the Pfizer/BioNTech Covid-19 vaccine [Internet].2020. Updated on 2021 Mar 8. Accessed on 28/12/2021. Available from: https://www.bna.bh/en/news?cms=q8FmFJgiscL2fwIzON1%2BDteRtB2wfPWh%2FOmYUjt6ApY%3D

Oliver SE. The advisory committee on immunization practices’ interim recommendation for use of moderna COVID-19 vaccine—United States, 2020. MMWR. Morbidity and mortality weekly report. 2021;69.Available from :https://www.cdc.gov/mmwr

ICMR.Covid-19 vaccines.[Internet].Accessed on 28/12/2021.Available from: https://vaccine.icmr.org.in/covid-19-vaccine

Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 2021; 397(10269):99–111. https://doi.org/10.1016/

Ministry Of Health and Family Welfare.FAQs on Covid-19 vaccines[Internet).Accessed on 28/12/2021. Available from :https://www.mohfw.gov.in/covid_vaccination/vaccination/index.html

Ritchie H, Ortiz-Ospina E, BeltekianD,MathieuE,HasellJ,MacdonaldB,et al. (2020) - "Coronavirus Pandemic (COVID-19)". Published online at OurWorldInData.org. [Internet).Accessed on28/12/2021. Available from: https://ourworldindata.org/coronavirus

Pottegård A, Lund L C, Karlstad O, Dahl J, Andersen M, Hallas J,et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZenecaChAdOx1-S in Denmark and Norway: population based cohort study.BMJ 2021;373:n1114 http://dx.doi.org/10.1136/bmj.n1114

Jeon M, Kim J, Oh CE, Lee J-Y. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System. J Korean Med Sci. 2021;36(17):e114.

EU countries suspend use of Covid-19 vaccine Astra Zeneca [Internet).UpdatedMarch 2021. Accessed on 28/12/2021. Available from: https://www.pharmaceutical-technology.com/news/european-countries-suspend-covid-19-az/

Kaushal SK, Patel AK, Yadav M, Kumar N. Assessment of adverse event following immunization and its co-relates among COVID-19 vaccine recipient in Bundelkhand region of Uttar Pradesh: A cross-sectional study. Indian J Comm Health. 2021;33(2):379-382. https://doi.org/10.47203/IJCH.2021.v33i02.027

CoWin. AEFI report.[Internet].Accessed on 28/12/2021. Available from https://www.cowin.gov.in/

Downloads

Published

2021-12-31

How to Cite

1.
Bhutia JL, Upreti B, Bhutia EJ, Kar S, Zaman FA. Adverse Events Following COVID-19 Vaccination among the Beneficiaries of Sikkim Manipal University: A Cross Sectional Study. Indian J Community Health [Internet]. 2021 Dec. 31 [cited 2024 Jul. 25];33(4):603-7. Available from: https://iapsmupuk.org/journal/index.php/IJCH/article/view/2235

Issue

Section

Original Article